Published in Women's Health Weekly, April 14th, 2005
The Phase III study is run by the National Surgical Adjuvant Breast and Bowel Project (NSABP) and the Radiation Therapy Oncology Group (RTOG), and sponsored by the U.S. National Cancer Institute. It will include 3,000 women with early stage breast cancer who have had a breast-conserving therapy called lumpectomy.
The women will be randomly assigned into one of two groups. Half of them will be assigned to receive whole breast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.